vTv Therapeutics Inc (VTVT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $78.99M
Last updated: Nov 17, 2026 at 11:05 AM ET
vTv Therapeutics Inc (VTVT) Competitors
The companies most similar to vTv Therapeutics are Tiziana Life Sciences (TLSA), Tenaya Therapeutics (TNYA) and Unicycive Therapeutics (UNCY). By market cap, vTv Therapeutics ranks 7th of the 13 companies on this page; Voyager Therapeutics (VYGR) is the largest at $107.66M.
Peer Comparison
VTVT's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| vTv Therapeutics (VTVT) | $78.99M | N/A | N/A | -20.8% | N/A | 0.0% | 0.00% |
| Tiziana Life Sciences Ltd (TLSA) | $72.53M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tenaya Therapeutics Inc (TNYA) | $79.59M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Unicycive Therapeutics Inc (UNCY) | $97.25M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tenax Therapeutics Inc (TENX) | $73.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Voyager Therapeutics Inc (VYGR) | $107.66M | N/A | 4.0x | 0.0% | N/A | -70.0% | 0.00% |
| Gain Therapeutics Inc (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| XBiotech Inc (XBIT) | $59.76M | N/A | N/A | 0.0% | N/A | -93.3% | 0.00% |
| TuHURA Biosciences Inc (HURA) | $88.58M | N/A | N/A | 0.0% | -81.8% | 0.0% | 0.00% |
| Pmv Pharmaceuticals Inc (PMVP) | $95.93M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| Cognition Therapeutics Inc (CGTX) | $64.65M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| OUTLOOK THERAPEUTICS INC (OTLK) | $100.54M | N/A | N/A | 0.0% | -776.9% | -99.4% | 0.00% |
| Peer median | $76.68M | N/A | 3.0x | 0.0% | -473.7% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to vTv Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Tiziana Life Sciences Ltd (TLSA) | Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat... | |
| Tenaya Therapeutics Inc (TNYA) | Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary... | TNYA competitors |
| Unicycive Therapeutics Inc (UNCY) | Unicycive Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on pioneering therapies for kidney diseases... | UNCY competitors |
| Tenax Therapeutics Inc (TENX) | Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing... | TENX competitors |
| Voyager Therapeutics Inc (VYGR) | Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases. | VYGR competitors |
| Gain Therapeutics Inc (GANX) | Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. | GANX competitors |
| XBiotech Inc (XBIT) | XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases. | XBIT competitors |
| TuHURA Biosciences Inc (HURA) | TuHURA Biosciences Inc is a pioneering biotechnology firm committed to advancing immunotherapy solutions for cancer and autoimmune diseases. | HURA competitors |
| Pmv Pharmaceuticals Inc (PMVP) | PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53... | PMVP competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| Cognition Therapeutics Inc (CGTX) | Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting... | CGTX competitors |
| OUTLOOK THERAPEUTICS INC (OTLK) | Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic... | OTLK competitors |
Frequently Asked Questions About VTVT
Who are vTv Therapeutics' main competitors?
The companies most similar to vTv Therapeutics include Tiziana Life Sciences (TLSA), Tenaya Therapeutics (TNYA), Unicycive Therapeutics (UNCY), Tenax Therapeutics (TENX) and Voyager Therapeutics (VYGR), listed from the closest match.
Who is vTv Therapeutics' biggest competitor?
Voyager Therapeutics (VYGR) is the largest of the similar companies at $107.66M; Tiziana Life Sciences (TLSA) is the closest match by business profile, size, sector and industry.
How does VTVT stock compare with its competitors?
VTVT's net margin is -20.8% against a peer median of 0.0%.
Which of vTv Therapeutics' competitors pays a higher dividend?
vTv Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is vTv Therapeutics bigger than its competitors?
No. vTv Therapeutics is 7th by market cap among the 13 companies on this page; the largest is Voyager Therapeutics (VYGR) at $107.66M.
VTVT pages: Overview, Earnings, Forecast, Financials, Competitors